- Home
- DYAI vs ABP Comparison
DYAI vs ABP Comparison
Compare DYAI & ABP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DYAI
- ABP
- Stock Information
- Founded
- DYAI 1979
- ABP N/A
- Country
- DYAI United States
- ABP United States
- Employees
- DYAI N/A
- ABP N/A
- Industry
- DYAI Biotechnology: Biological Products (No Diagnostic Substances)
- ABP Biotechnology: Pharmaceutical Preparations
- Sector
- DYAI Health Care
- ABP Health Care
- Exchange
- DYAI Nasdaq
- ABP Nasdaq
- Market Cap
- DYAI 31.5M
- ABP 29.8M
- IPO Year
- DYAI 2004
- ABP 2022
- Fundamental
- Price
- DYAI $1.13
- ABP N/A
- Analyst Decision
- DYAI Strong Buy
- ABP
- Analyst Count
- DYAI 1
- ABP 0
- Target Price
- DYAI $6.00
- ABP N/A
- AVG Volume (30 Days)
- DYAI 18.7K
- ABP N/A
- Earning Date
- DYAI 11-12-2024
- ABP N/A
- Dividend Yield
- DYAI N/A
- ABP N/A
- EPS Growth
- DYAI N/A
- ABP N/A
- EPS
- DYAI N/A
- ABP N/A
- Revenue
- DYAI $3,364,548.00
- ABP N/A
- Revenue This Year
- DYAI $2.04
- ABP N/A
- Revenue Next Year
- DYAI $110.34
- ABP N/A
- P/E Ratio
- DYAI N/A
- ABP N/A
- Revenue Growth
- DYAI 13.82
- ABP N/A
- 52 Week Low
- DYAI $0.93
- ABP N/A
- 52 Week High
- DYAI $2.67
- ABP N/A
- Technical
- Relative Strength Index (RSI)
- DYAI 52.65
- ABP N/A
- Support Level
- DYAI $1.02
- ABP N/A
- Resistance Level
- DYAI $1.23
- ABP N/A
- Average True Range (ATR)
- DYAI 0.09
- ABP 0.00
- MACD
- DYAI 0.01
- ABP 0.00
- Stochastic Oscillator
- DYAI 52.33
- ABP 0.00
About DYAI Dyadic International Inc.
Dyadic International Inc is a world-wide biotechnology platform company. The company has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins, and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.